Filing metadata

Accession number
0001600620-24-000124
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Nov 25, 2024
Reporting period
Nov 21, 2024
Description
Insider transaction

Explore SEC Filings Hub